Skip to content
10-Q

Quarterly Report

YIELD10 BIOSCIENCE, INC.

0001121702-24-000046

← back to feed
Filed
May 15, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 14, 2024 642.55K sh
Shares Diluted Q1 2024 · Mar 31, 2024 518.53K sh
Shares Diluted restated Q1 2024 · Mar 31, 2023 208.32K sh
Capex Q1 2024 · Mar 31, 2024 $0
Capex Q1 2024 · Mar 31, 2023 $9K
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$903K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$2.67M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $1.6M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $1.07M
Stockholders Equity Q1 2024 · Mar 31, 2024 −$3.31M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$2.48M
Stockholders Equity Q1 2024 · Mar 31, 2023 $1.14M
Stockholders Equity Q1 2024 · Dec 31, 2022 $4.4M
Current Liabilities Q1 2024 · Mar 31, 2024 $6.21M
Current Liabilities Q1 2024 · Dec 31, 2023 $4.87M
Total Liabilities Q1 2024 · Mar 31, 2024 $7.56M
Total Liabilities Q1 2024 · Dec 31, 2023 $6.39M
Current Assets Q1 2024 · Mar 31, 2024 $2.12M
Current Assets Q1 2024 · Dec 31, 2023 $1.4M
Total Assets Q1 2024 · Mar 31, 2024 $4.24M
Total Assets Q1 2024 · Dec 31, 2023 $3.91M
Eps Diluted Q1 2024 · Mar 31, 2024 −$4.77
Eps Diluted restated Q1 2024 · Mar 31, 2023 −$18.16
Eps Basic Q1 2024 · Mar 31, 2024 −$4.77
Eps Basic restated Q1 2024 · Mar 31, 2023 −$18.16
Sga Expense Q1 2024 · Mar 31, 2024 $1.37M
Sga Expense Q1 2024 · Mar 31, 2023 $1.7M
Net Income Q1 2024 · Mar 31, 2024 −$2.47M
Net Income Q1 2024 · Mar 31, 2023 −$3.78M
Operating Income Q1 2024 · Mar 31, 2024 −$2.44M
Operating Income Q1 2024 · Mar 31, 2023 −$3.8M
Revenue Q1 2024 · Mar 31, 2024 $300K
Revenue Q1 2024 · Mar 31, 2023 $60K